Practice Location

15000 N 83RD AVE UNIT 300
PEORIA, AZ 85381-2004

Phone: (602) 238-7490

What does PARMJEET BANGHAR research?

Dr. Banghar studies hereditary spherocytosis (HS), which is a genetic condition that causes red blood cells to become misshapen and fragile. He emphasizes the symptoms patients experience, such as jaundice (yellowing of the skin caused by high bilirubin levels), fever, and weakness. His research also highlights the effectiveness of treatments, particularly the impact of spleen removal in alleviating these symptoms for affected individuals.

Key findings

  • In a study of 145 patients, 67% experienced jaundice, 66% had fever, and 45% reported weakness.
  • 94.5% of patients had an enlarged spleen, which is common among those with hereditary spherocytosis.
  • 87% of patients who were evaluated by other doctors had their spherocytes (abnormal red blood cells) missed in previous diagnoses.

Frequently asked questions

Does Dr. Banghar study hereditary spherocytosis?
Yes, Dr. Banghar specializes in hereditary spherocytosis, focusing on its symptoms and treatment.
What treatments has Dr. Banghar researched for hereditary spherocytosis?
He has researched the effectiveness of spleen removal surgery as a treatment to improve symptoms.
Is Dr. Banghar's work relevant to patients with jaundice?
Yes, his research addresses jaundice as one of the primary symptoms of hereditary spherocytosis.

Publications in plain English

Early identification of M2 AML with the (8;21) translocation plus myelodysplastic features.

1995

Leukemia research

Galvani DW, Banghar P, Mekawi L

PubMed

Hereditary spherocytosis: experience of 145 cases.

1992

Indian journal of medical sciences

Mehta J, Harjai K, Vasani J, Banghar P, Sanklecha M +5 more

Plain English
This study looked at 145 patients diagnosed with hereditary spherocytosis (HS) over 25 years. Researchers found that most patients experienced jaundice (67%), fever (66%), and weakness (45%). Nearly all patients (94.5%) had an enlarged spleen, and spherocytes, which are abnormal red blood cells, were present in all cases; interestingly, almost 87% of patients investigated elsewhere had missed these spherocytes. Removing the spleen improved symptoms for those who underwent surgery. Who this helps: Patients with hereditary spherocytosis.

PubMed

Frequent Co-Authors

D W Galvani L Mekawi J Mehta K Harjai J Vasani M Sanklecha S Singhal A Pathare G H Tilve B C Mehta

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.